Last week Jarrod and I spent our Friday at NIH. We were filling out paperwork and getting my blood drawn to see if I qualify for an immunotherapy trial that is actually including some sarcoma patients. It's exciting, and futuristic, and scary, and hope-giving all at the same time. Basically, the